What is the growth forecast for the GBS Nucleic Acid Detection Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the GBS Nucleic Acid Detection Kit market?

Increasing demand for rapid diagnosis and rising awareness of Group B Streptococcus infections.

What are the major challenges facing the GBS Nucleic Acid Detection Kit market?

High costs of nucleic acid detection kits and lack of awareness in developing regions.

Which regions are leading the GBS Nucleic Acid Detection Kit market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the GBS Nucleic Acid Detection Kit market?

Prominent players include Roche, Abbott, and bioMerieux, offering innovative detection solutions.

What future opportunities exist in the GBS Nucleic Acid Detection Kit market?

Emerging markets and technological advancements in nucleic acid detection are expected to drive growth.

How is technology impacting the GBS Nucleic Acid Detection Kit market?

Advances in molecular diagnostics and point-of-care testing are improving detection accuracy and speed.

What is the regulatory landscape like for the GBS Nucleic Acid Detection Kit market?

Regulatory bodies such as the FDA and CE mark are ensuring compliance with safety and efficacy standards.

What is the future outlook for the GBS Nucleic Acid Detection Kit market?

The market is expected to witness significant growth due to increasing demand for rapid and accurate detection methods.

Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Potential & Strategic Outlook 2033

Group B Streptococcus (GBS) Nucleic Acid Detection Kit by Application (Hospital, Clinic, Other), by Types (Less than 20 pieces / box, More than 20 pieces / box), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Overview

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit market is a crucial segment of the in vitro diagnostics industry, playing a significant role in the prevention of GBS infections in newborns. As the GBS Nucleic Acid Detection Kit market size is estimated to be around $543.8 million in 2025, the growth outlook for this market is promising, with a projected market forecast of $1.23 billion by 2033, driven by the increasing awareness of GBS infections and the need for accurate diagnosis. The industry expansion is expected to be driven by the rising demand for molecular diagnostic tests, with a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts towards PCR-based testing, regulations promoting the use of nucleic acid detection kits, and consumer behavior driving the demand for non-invasive diagnostic tests.

Loading chart…

The largest region in the GBS Nucleic Acid Detection Kit market is North America, accounting for approximately 45% of the global market share, while the fastest-growing region is Asia Pacific, driven by the increasing adoption of molecular diagnostic tests in countries such as China and India. The market is expected to be driven by the increasing demand for accurate and rapid diagnostic tests, with key players focusing on developing innovative products and expanding their distribution networks to capitalize on the growing demand.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	TIANLONG; Bioperfectus Technologies; COYOTE; Hybribio; Biochain (Beijing) Science-Technology; Luminex; TIB; ZJ Bio-Tech; Daan Gene; Biotron
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit market is experiencing significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market size and growth forecast.

Growth Drivers2 items

Increasing demand for rapid and accurate diagnostic tests for Group B Streptococcus (GBS) infections, particularly among pregnant women, is driving the adoption of nucleic acid detection kits.

Advancements in molecular diagnostic technologies, such as PCR and DNA sequencing, have improved the sensitivity and specificity of GBS nucleic acid detection kits, contributing to market growth.

Restraints2 items

High costs associated with the development and implementation of nucleic acid detection kits, particularly in resource-constrained settings, are limiting their adoption and restraining market growth.

Stringent regulatory requirements and the need for specialized expertise to operate and interpret nucleic acid detection kits are also hindering the widespread adoption of these products.

Opportunities2 items

The growing awareness of Group B Streptococcus (GBS) infections and their potential consequences, particularly in newborns, is creating opportunities for the development and marketing of nucleic acid detection kits.

The increasing use of point-of-care diagnostic tests and the expansion of healthcare infrastructure in emerging economies are also expected to drive the growth of the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market.

Challenges2 items

The presence of false-positive results and the potential for contamination during the testing process are significant challenges that need to be addressed by manufacturers of nucleic acid detection kits.

The competitive landscape of the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market is also expected to pose challenges, with several established players and new entrants vying for market share, which may impact the overall growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment of the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market refers to the various uses of these kits in different settings. This segment is crucial in understanding the Group B Streptococcus (GBS) Nucleic Acid Detection Kit segmentation and its impact on the overall market size. The application segment includes prenatal screening, neonatal care, and research institutions, among others. Each of these applications contributes to the market size, with prenatal screening being a significant contributor due to the high demand for GBS testing in pregnant women.

The Types segment of the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market is categorized into different subtypes, including PCR-based kits, DNA microarray kits, and others. Understanding the market taxonomy of these types is essential for analyzing the market's growth prospects. The types segment is significant, as it influences the market size and growth rate. For instance, PCR-based kits are widely used due to their high sensitivity and specificity, contributing substantially to the overall market size.

Group B Streptococcus (GBS) Nucleic Acid Detection Kit Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Less than 20 pieces / box

More than 20 pieces / box

Regional Insights

Loading chart…

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of nucleic acid detection kits, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large patient population. In Europe, drivers include demographics with an aging population, increased awareness about GBS, and developed healthcare systems. Asia Pacific's growth is fueled by a large and growing population, increasing healthcare expenditure, and rising demand for advanced diagnostic tools.

Latin America and Middle East & Africa are expected to experience steady growth, driven by improving healthcare infrastructure, government initiatives to enhance diagnostic capabilities, and a growing focus on preventive care. Understanding these regional dynamics is crucial for stakeholders to navigate the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market and capitalize on emerging opportunities, ultimately contributing to the regional forecast.

Competitive Landscape

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit market exhibits a moderately consolidated structure, with a mix of global players and local companies competing for market share. The Group B Streptococcus (GBS) Nucleic Acid Detection Kit competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and localization.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

TIANLONG: regional expansion

Bioperfectus Technologies: innovation pipeline

COYOTE: premium pricing

Hybribio: OEM tie-ups

Biochain (Beijing) Science-Technology: local manufacturing

Luminex: vertical integration

Key Group B Streptococcus (GBS) Nucleic Acid Detection Kit Companies10 items

TIANLONG

Bioperfectus Technologies

COYOTE

Hybribio

Biochain (Beijing) Science-Technology

Luminex

TIB

ZJ Bio-Tech

Daan Gene

Biotron

Market Ecosystem

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Technology providers and suppliers deliver essential components, which are then integrated by manufacturers and system integrators. These solutions are subsequently distributed through various channels to reach end users, including healthcare facilities and laboratories. Value is created and captured at each stage, from research and development to commercialization and after-sales support.

Raw material suppliers — provide nucleic acid extraction reagents

OEMs/manufacturers — produce GBS detection kits

Technology providers — develop nucleic acid detection technologies

System integrators/EPCs — integrate kits into laboratory workflows

Distributors/channel partners — supply kits to healthcare facilities

Regulators/standards bodies — establish testing and validation standards

End users/buyers — utilize GBS detection kits for patient testing

In the Group B Streptococcus (GBS) Nucleic Acid Detection Kit ecosystem, control points are primarily held by regulatory bodies and end users, who influence adoption through standards and purchasing decisions. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact manufacturers' ability to produce and distribute kits. Switching costs and interoperability requirements also affect the ecosystem, as laboratories and healthcare facilities may be hesitant to change suppliers or integrate new systems. Furthermore, regional differences in regulations, healthcare infrastructure, and market demands can lead to variations in the ecosystem across different regions, highlighting the need for a thorough value chain analysis to understand these complexities.

Recent Industry Insights

The Group B Streptococcus (GBS) Nucleic Acid Detection Kit industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between major market players, such as collaborations between diagnostic companies and research institutions, to enhance the accuracy and efficiency of GBS nucleic acid detection kits. Furthermore, there have been strategic mergers and acquisitions, aiming to expand product portfolios and strengthen market presence.

Recent product launches have focused on innovative technologies, including rapid molecular diagnostic tests, to improve the detection of Group B Streptococcus. Regulatory changes have also played a crucial role, with updated guidelines emphasizing the importance of accurate and timely GBS detection in prenatal care. Additionally, funding rounds have been secured by several companies to support the development of novel nucleic acid detection kits, driving growth in the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Group B Streptococcus (GBS) Nucleic Acid Detection Kit market. The market attractiveness is moderate, driven by the increasing prevalence of GBS infections and the need for accurate diagnostic tools. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the GBS Nucleic Acid Detection Kit market outlook is positive, with growing demand for molecular diagnostic tests.

The innovation landscape is rapidly evolving, with advancements in nucleic acid detection technologies and the development of more sensitive and specific diagnostic kits. However, the demand–supply balance is a key concern, with potential shortages of raw materials and manufacturing capacity constraints. Key risk factors include regulatory changes, reimbursement issues, and the emergence of new diagnostic technologies that could disrupt the market.

12 items

1. Executive Summary

2. Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Competition by Key Manufacturers

9.1. Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. TIANLONG

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bioperfectus Technologies

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. COYOTE

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hybribio

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biochain (Beijing) Science-Technology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Luminex

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. TIB

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ZJ Bio-Tech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Daan Gene

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Biotron

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market

Figure 4: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Drivers

Figure 5: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Challenges

Figure 6: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Trends

Figure 7: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Opportunity

Figure 8: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Restraint

Figure 9: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Value (USD Million) By Region

Figure 19: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Value (USD Million) By Region

Figure 27: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By: Regions (2032)

Figure 28: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) By Region

Figure 29: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Value (USD Million) By Region

Figure 37: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By: Regions (2032)

Figure 38: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) By Region

Figure 39: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Value (USD Million) By Region

Table 14: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) By Region

Table 31: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: TIANLONG Basic Information And Sales Area

Table 52: TIANLONG. Products Portfolio

Table 53: Bioperfectus Technologies Basic Information And Sales Area

Table 54: Bioperfectus Technologies. Products Portfolio

Table 55: COYOTE Basic Information And Sales Area

Table 56: COYOTE. Products Portfolio

Table 57: Hybribio Basic Information And Sales Area

Table 58: Hybribio. Products Portfolio

Table 59: Biochain (Beijing) Science-Technology Basic Information And Sales Area

Table 60: Biochain (Beijing) Science-Technology. Products Portfolio

Table 61: Luminex Basic Information And Sales Area

Table 62: Luminex. Products Portfolio

Table 63: TIB Basic Information And Sales Area

Table 64: TIB. Products Portfolio

Table 65: ZJ Bio-Tech Basic Information And Sales Area

Table 66: ZJ Bio-Tech. Products Portfolio

Table 67: Daan Gene Basic Information And Sales Area

Table 68: Daan Gene. Products Portfolio

Table 69: Biotron Basic Information And Sales Area

Table 70: Biotron. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Value (USD Million) By Region

Table 80: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Volume (K) By Region

Table 97: Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	TIANLONG; Bioperfectus Technologies; COYOTE; Hybribio; Biochain (Beijing) Science-Technology; Luminex; TIB; ZJ Bio-Tech; Daan Gene; Biotron
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for rapid and accurate diagnostic tests for Group B Streptococcus (GBS) infections, particularly among pregnant women, is driving the adoption of nucleic acid detection kits.

Advancements in molecular diagnostic technologies, such as PCR and DNA sequencing, have improved the sensitivity and specificity of GBS nucleic acid detection kits, contributing to market growth.

Restraints2 items

High costs associated with the development and implementation of nucleic acid detection kits, particularly in resource-constrained settings, are limiting their adoption and restraining market growth.

Stringent regulatory requirements and the need for specialized expertise to operate and interpret nucleic acid detection kits are also hindering the widespread adoption of these products.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Group B Streptococcus (GBS) Nucleic Acid Detection Kit Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Less than 20 pieces / box

More than 20 pieces / box

Regional Insights

Loading chart…

Competitive Landscape

TIANLONG: regional expansion

Bioperfectus Technologies: innovation pipeline

COYOTE: premium pricing

Hybribio: OEM tie-ups

Biochain (Beijing) Science-Technology: local manufacturing

Luminex: vertical integration

Key Group B Streptococcus (GBS) Nucleic Acid Detection Kit Companies10 items

TIANLONG

Bioperfectus Technologies

COYOTE

Hybribio

Biochain (Beijing) Science-Technology

Luminex

TIB

ZJ Bio-Tech

Daan Gene

Biotron

Market Ecosystem

Raw material suppliers — provide nucleic acid extraction reagents

OEMs/manufacturers — produce GBS detection kits

Technology providers — develop nucleic acid detection technologies

System integrators/EPCs — integrate kits into laboratory workflows

Distributors/channel partners — supply kits to healthcare facilities

Regulators/standards bodies — establish testing and validation standards

End users/buyers — utilize GBS detection kits for patient testing

Recent Industry Insights

Analyst Overview

Table of Contents